|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HPV mRNA E6-E7rfx 16, 18-45
Test CodeLAB5184
Quest Code
90942X
CPT Codes
87624
Includes
If HPV mRNA E6/E7 is detected, HPV Genotypes 16, 18/45 will be performed at an additional charge (CPT Code(s): 87625).
Preferred Specimen
5 mL Liquid Cytology (PreservCyt(R)) Preservative
(ThinPrep(R))
(ThinPrep(R))
Minimum Volume
1 mL
Specimen Stability
Room temperature: 30 days
Refrigerated: 90 days
Frozen: Unacceptable
Refrigerated: 90 days
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Cervical swabs in Digene(R) HC Cervical Sampler,
Digene(R)vials, Vaginal swabs, SurePath(R) vials,
Received frozen
Digene(R)vials, Vaginal swabs, SurePath(R) vials,
Received frozen
Methodology
Transcription-Mediated Amplification (TMA)
Setup Schedule
Set up: Mon-Fri a.m.; Report available: 3 days
Reference Range
HPV mRNA E6/E7 | Not detected |
This assay detects E6/E7 viral messenger RNA (mRNA) from 14 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68).
Clinical Significance
The presence of E6/E7 messenger RNA from 14 high risk HPV types indicates incorporation of HPV DNA into the host cells. Proteins expressed from E6-E7 polycistronic mRNA alter cellular p53 and retinoblastoma protein functions, leading to disruption of cell-cycle check points and cell genome instability. This information, together with the physicians assessment of cytology history, other risk factors, and professional guidelines, may be used to guide patient management.
This assay detects E6/E7 viral messenger RNA (mRNA) from 14 high-risk HPV types (16,18,31,33,35,39,45,51,52,56,58, 59,66,68).
This assay detects E6/E7 viral messenger RNA (mRNA) from 14 high-risk HPV types (16,18,31,33,35,39,45,51,52,56,58, 59,66,68).